Malar J

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.O'Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D
Malar J, (2011). 10:326

The ACTwatch project: methods to describe anti-malarial markets in seven countries.Shewchuk T, O'Connell KA, Goodman C, Hanson K, Chapman S, Chavasse D
Malar J, (2011). 10:325

Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Lawford H, Zurovac D, O'Reilly L, Hoibak S, Cowley A, Munga S, Vulule J, Juma E, Snow RW, Allan R
Malar J, (2011). 10:281

Cost analysis of school-based intermittent screening and treatment of malaria in Kenya.Drake TL, Okello G, Njagi K, Halliday KE, Jukes MC, Mangham L, Brooker S
Malar J, (2011). 10:273

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.Swysen C, Vekemans J, Bruls M, Oyakhirome S, Drakeley C, Kremsner P, Greenwood B, Ofori-Anyinam O, Okech B, Villafana T, Carter T, Savarese B, Duse A, Reijman A, Ingram C, Frean J, Ogutu B
Malar J, (2011). 10:223

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.Vekemans J, Marsh K, Greenwood B, Leach A, Kabore W, Soulanoudjingar S, Asante KP, Ansong D, Evans J, Sacarlal J, Bejon P, Kamthunzi P, Salim N, Njuguna P, Hamel MJ, Otieno W, Gesase S, Schellenberg D
Malar J, (2011). 10:221

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.Lievens M, Aponte JJ, Williamson J, Mmbando B, Mohamed A, Bejon P, Leach A
Malar J, (2011). 10:222

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.Leach A, Vekemans J, Lievens M, Ofori-Anyinam O, Cahill C, Owusu-Agyei S, Abdulla S, Macete E, Njuguna P, Savarese B, Loucq C, Ballou WR
Malar J, (2011). 10:224

Global proteomic analysis of plasma from mice infected with Plasmodium berghei ANKA using two dimensional gel electrophoresis and matrix assisted laser desorption ionization-time of flight mass spectrometry.Gitau EN, Kokwaro GO, Newton CR, Ward SA
Malar J, (2011). 10:205

Treatment of African children with severe malaria - towards evidence-informed clinical practice using GRADE.Musila N, Opiyo N, English M
Malar J, (2011). 10:201

The clinical burden of malaria in Nairobi: a historical review and contemporary audit.Mudhune SA, Okiro EA, Noor AM, Zurovac D, Juma E, Ochola SA, Snow RW
Malar J, (2011). 10:138

Self-reported fever, treatment actions and malaria infection prevalence in the northern states of Sudan.Elmardi KA, Noor AM, Githinji S, Abdelgadir TM, Malik EM, Snow RW
Malar J, (2011). 10:128

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.Chilengi R, Juma R, Abdallah AM, Bashraheil M, Lodenyo H, Nyakundi P, Anabwani E, Salim A, Mwambingu G, Wenwa E, Jemutai J, Kipkeu C, Oyoo GO, Muchohi SN, Kokwaro G, Niehues T, Lang T, Nzila A
Malar J, (2011). 10:63

Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study.Muema DK, Ndungu FM, Kinyanjui SM, Berkley JA
Malar J, (2011). 10:55

School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings.Ashton RA, Kefyalew T, Tesfaye G, Pullan RL, Yadeta D, Reithinger R, Kolaczinski JH, Brooker S
Malar J, (2011). 10:25

Changes in health workers' malaria diagnosis and treatment practices in Kenya.Juma E, Zurovac D
Malar J, (2011). 10:1

Is vaccine the magic bullet for malaria elimination? A reality check.Chilengi R, Gitaka J
Malar J, (2010). 9 Suppl 3:S1

Congenital and neonatal malaria in a rural Kenyan district hospital: an eight-year analysis.Mwaniki MK, Talbert AW, Mturi FN, Berkley JA, Kager P, Marsh K, Newton CR
Malar J, (2010). 9:313

Changing trends in blood transfusion in children and neonates admitted in Kilifi District Hospital, Kenya.Pedro R, Akech S, Fegan G, Maitland K
Malar J, (2010). 9:307

Implementing school malaria surveys in Kenya: towards a national surveillance system.Gitonga CW, Karanja PN, Kihara J, Mwanje M, Juma E, Snow RW, Noor AM, Brooker S
Malar J, (2010). 9:306